- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
This paper present AMP-UGen a model that combines AMP understanding and AMP generation. The paper first finetune an LLM to understand peptide embeddings from ESM2. Then the paper proposes Understanding-to-Design Transfer (UDT) to aggregate peptide design query features from the finetuned LLM. The aggregated features are then conditioned into a masked diffusion model to generate peptide. To further transfer the understanding knowlege for peptide generation, this paper propose Understanding-Feedback Policy Optimization (UFPO) to train the diffusion model align with the three customized reward goals. Experiments demonstrate the effectiveness of the proposed AMP-UGen model.
Critical strengths
- This paper is well-written and easy to follow.
- The paper is well motivated. The methodology well justified the motivation.
- The idea os reusing the understanding model in UFPO is a brilliant idea.
Critical weaknesses
Although the paper propose some interesting ideas. I do have some major comments on the evaluation part.
-
The paper heavily rely on existing models for evaluation as mentioned from lines 416 to 419. I do not think they are wrong. But since every ML models has bias towards certain distribution, solely rely on them might not enough to estimate the performance of the model. There could be more other quantitative and qualitative studies. For instance, the pLDDT score in co-folding model to evaluate the folding of the sequence (alpha helix, beta hairpin, or random coil). MD simulation could also be applied on certain amount generated sequences for simulating the interaction between sequences and membrane.
-
It is unclear to me how are charge success and moment success defined in the paper. To be clear, normally AMPs carry a net positive charge between 3 to 9. It is not the higher the better. It is because the membranes are usully negative charged. Similarly, AMPs usually has 30% and 50% hydrophobic residues. Over 50% might cause the sequence insoluble in water.
-
Fig 3 does not make a lot of sense to me. Since UPFO directly optimize Net charges and Hydrophobic moment, the distribution naturally shift to the target. But this does not directly prove the model is genreating new AMPs that satisfy the target and predicted antimicrobial quality (stated in line 475).
-
AMP generation baselines could be more comprehensive. Some similar reward based model can be included such as,
Tang, Sophia, Yinuo Zhang, and Pranam Chatterjee. "Peptune: De novo generation of therapeutic peptides with multi-objective-guided discrete diffusion." ArXiv (2025): arXiv-2412.
Cao, Hanqun, Haosen Shi, Chenyu Wang, Sinno Pan, and Pheng-Ann Heng. "GLID e: A gradient-free lightweight fine-tune approach for discrete biological sequence design." Advances in Neural Information Processing Systems 38 (2026): 139875-139898.
- Some typo and grammar errors noted. Some symbol in method section is not well defined. The presentation can be further improved, such as the placement of Table 1.
Overall, this is an interesting paper. I put a weak rejection for now. But I am willing to increase my rating if the rebuttal can address most of my concern.
Questions for authors
- How is the charge and moment success defined.